{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T08:38:36Z","timestamp":1782463116776,"version":"3.54.5"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2008,2,13]],"date-time":"2008-02-13T00:00:00Z","timestamp":1202860800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurocrit Care"],"published-print":{"date-parts":[[2008,8]]},"DOI":"10.1007\/s12028-008-9065-z","type":"journal-article","created":{"date-parts":[[2008,3,20]],"date-time":"2008-03-20T18:42:29Z","timestamp":1206038549000},"page":"122-124","source":"Crossref","is-referenced-by-count":25,"title":["Propylene Glycol Toxicity Complicating Use of Barbiturate Coma"],"prefix":"10.1007","volume":"9","author":[{"given":"Kathleen A.","family":"Bledsoe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas H.","family":"Kramer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,2,13]]},"reference":[{"key":"9065_CR1","doi-asserted-by":"crossref","first-page":"S71","DOI":"10.1089\/neu.2007.9985","volume":"24","author":"Brain Trauma Foundation; American Association of Neurological Surgeons; Congress of Neurological Surgeons; Joint Section on Neurotrauma, Critical Care AANS\/CNS","year":"2007","unstructured":"Brain Trauma Foundation; American Association of Neurological Surgeons; Congress of Neurological Surgeons; Joint Section on Neurotrauma, Critical Care AANS\/CNS. Anesthetics, analgesics, and sedatives. J Neurotrauma 2007;24:S71\u20136.","journal-title":"J Neurotrauma"},{"key":"9065_CR2","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3171\/jns.1988.69.1.0015","volume":"69","author":"HM Eisenberg","year":"1988","unstructured":"Eisenberg HM, Frankowski RF, Contant CF, Marshall LF, Walker MD. High-dose barbiturate control of elevated intracranial pressure in patients with severe head injury. J Neurosurg 1988;69:15\u201323.","journal-title":"J Neurosurg"},{"key":"9065_CR3","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1136\/bmj.282.6263.520","volume":"282","author":"M Partinen","year":"1981","unstructured":"Partinen M, Kovanen J, Nilsson E. Status epilepticus treated by barbiturate anaesthesia with continuous monitoring of cerebral function. BMJ 1981;282:520\u20131.","journal-title":"BMJ"},{"key":"9065_CR4","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1212\/01.WNL.0000032253.88378.D7","volume":"59","author":"I Parviainen","year":"2002","unstructured":"Parviainen I, Uusaro A, Kalviainen R, Kaukanen E, Mervaala E, Ruokonen E. High-dose thiopental in the treatment of refractory status epilepticus in intensive care unit. Neurology 2002;59:1249\u201351.","journal-title":"Neurology"},{"key":"9065_CR5","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1046\/j.1528-1157.2002.28501.x","volume":"43","author":"J Claassen","year":"2002","unstructured":"Claassen J, Hirsch LJ, Emerson RG, Mayer SA. Treatment of refractory status epilepticus with pentobarbital, propofol, or midazolam: a systematic review. Epilepsia 2002;43:146\u201353.","journal-title":"Epilepsia"},{"key":"9065_CR6","unstructured":"Reves JG, Glass PSA, Lubarsky DA, McEvoy MD. Intravenous nonopioid anesthetics. In: Miller\u2019s anesthesia. 6th ed. Philadelphia: Elsevier Inc; 2005. pp. 326\u201334."},{"key":"9065_CR7","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1399-6576.1992.tb03483.x","volume":"36","author":"W Schalen","year":"1992","unstructured":"Schalen W, Messeter K, Nordstrom CH. Complications and side effects during thiopentone therapy in patients with severe head injuries. Acta Anaesthesiol Scan 1992;36:369\u201377.","journal-title":"Acta Anaesthesiol Scan"},{"key":"9065_CR8","doi-asserted-by":"crossref","unstructured":"Todd MM, Drummond JC, U HS. The hemodynamic consequences of high-dose thiopental anesthesia. Anesth Analg 1985;64:681\u20137.","DOI":"10.1213\/00000539-198507000-00006"},{"key":"9065_CR9","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1097\/00000542-196107000-00002","volume":"22","author":"JW Eckstein","year":"1961","unstructured":"Eckstein JW, Hamilton WK, McCammond JM. The effect of thiopental on peripheral venous tone. Anesthesiology 1961;22:525\u20138.","journal-title":"Anesthesiology"},{"key":"9065_CR10","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1097\/00000542-198504000-00012","volume":"62","author":"SD Choi","year":"1985","unstructured":"Choi SD, Spaulding BC, Gross JB, Apfelbaum JL. Comparison of the ventilatory effects of etomidate and methohexital. Anesthesiology 1985;62:442\u20137.","journal-title":"Anesthesiology"},{"key":"9065_CR11","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1007\/s00134-002-1399-y","volume":"28","author":"CJ Cairns","year":"2002","unstructured":"Cairns CJ, Thomas B, Fletcher S, Parr MJ, Finfer SR. Life-threatening hyperkalemia following therapeutic barbiturate coma. Intensive Care Med 2002;28:1357\u201360.","journal-title":"Intensive Care Med"},{"key":"9065_CR12","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/BF03346316","volume":"30","author":"JA Llompart-Pou","year":"2007","unstructured":"Llompart-Pou JA, Perez-Barcena J, Raurich JM, et\u00a0al. Effect of barbiturate coma on adrenal response in patients with traumatic brain injury. J Endocrinol Invest 2007;30:393\u20138.","journal-title":"J Endocrinol Invest"},{"key":"9065_CR13","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/BF01704886","volume":"20","author":"KEW Eberhardt","year":"1992","unstructured":"Eberhardt KEW, Thimm BM, Spring A, Maskos WR. Dose-dependent rate of nosocomial pulmonary infection in mechanically ventilated patients with brain edema receiving barbiturates: a prospective case study. Infection 1992;20:12\u20138.","journal-title":"Infection"},{"key":"9065_CR14","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s002280050508","volume":"54","author":"JF Stover","year":"1998","unstructured":"Stover JF, Stocker R. Barbiturate coma may promote reversible bone marrow suppression in patients with severe isolated traumatic brain injury. Eur J Clin Pharmacol 1998;54:529\u201334.","journal-title":"Eur J Clin Pharmacol"},{"key":"9065_CR15","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1097\/01.CCM.0000199067.71968.6E","volume":"34","author":"A Ploppa","year":"2006","unstructured":"Ploppa A, Kiefer RT, Nohe B, et\u00a0al. Dose-dependent influence of barbiturates but not of propofol on human leukocyte phagocytosis of viable Staphylococcus aureus. Crit Care Med 2006;34:478\u201383.","journal-title":"Crit Care Med"},{"key":"9065_CR16","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/j.1525-139X.2007.00280.x","volume":"20","author":"T Zar","year":"2007","unstructured":"Zar T, Graeber C, Perazella MA. Recognition, treatment, and prevention of propylene glycol toxicity. Semin Dialysis 2007;20:217\u20139.","journal-title":"Semin Dialysis"},{"key":"9065_CR17","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1056\/NEJM200204183461618","volume":"346","author":"J Tayar","year":"2002","unstructured":"Tayar J, Jabbour G, Saggi SJ. Severe hyperosmolar metabolic acidosis due to a large dose of intravenous lorazepam. N Engl J Med 2002;346:1253\u20134.","journal-title":"N Engl J Med"},{"key":"9065_CR18","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s00134-001-1125-1","volume":"28","author":"MG Parker","year":"2002","unstructured":"Parker MG, Fraser GL, Watson DM, Riker RR. Removal of propylene glycol and correction of increased osmolar gap by hemodialysis in a patient on high dose lorazepam infusion therapy. Intensive Care Med 2002;28:81\u20134.","journal-title":"Intensive Care Med"},{"key":"9065_CR19","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1097\/01.CCM.0000134831.40466.39","volume":"32","author":"AC Arroliga","year":"2004","unstructured":"Arroliga AC, Shehab N, McCarthy K, Gonzales JP. Relationship of continuous infusion lorazepam to serum propylene glycol concentration in critically ill adults. Crit Care Med 2004;32:1709\u201314.","journal-title":"Crit Care Med"},{"key":"9065_CR20","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1378\/chest.128.3.1674","volume":"128","author":"KC Wilson","year":"2005","unstructured":"Wilson KC, Reardon C, Theodore AC, Farber HW. Propylene glycol toxicity: a severe iatrogenic illness in ICU patients receiving IV benzodiazepines: a case series an prospective, observational pilot study. Chest 2005;128:1674\u201381.","journal-title":"Chest"},{"key":"9065_CR21","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/00003246-200201000-00020","volume":"30","author":"J Jacobi","year":"2002","unstructured":"Jacobi J, Fraser GL, Coursin DB, et\u00a0al. Clinical practice guidelines for the sustained use of sedatives and analgesics in the critically ill adult. Crit Care Med 2002;30:119\u201341.","journal-title":"Crit Care Med"},{"key":"9065_CR22","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1097\/00003246-198705000-00021","volume":"15","author":"HE Demey","year":"1987","unstructured":"Demey HE, Bossaert LL. Propylene glycol intoxication and nitroglycerin therapy. Crit Care Med 1987;15:540.","journal-title":"Crit Care Med"},{"key":"9065_CR23","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1056\/NEJM200009143431115","volume":"343","author":"KC Wilson","year":"2000","unstructured":"Wilson KC, Reardon C, Farber HW. Propylene glycol toxicity. N Engl J Med 2000;343:815.","journal-title":"N Engl J Med"},{"key":"9065_CR24","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1001\/archinte.1991.00400110137026","volume":"151","author":"E Bedichek","year":"1991","unstructured":"Bedichek E, Kirschbaum B. A case of propylene glycol toxic reaction associated with etomidate infusion. Arch Intern Med 1991;151:2297\u20138.","journal-title":"Arch Intern Med"},{"key":"9065_CR25","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1227\/00006123-199508000-00035","volume":"37","author":"ML Levy","year":"1995","unstructured":"Levy ML, Aranda M, Zelman V, Giannotta SL. Toxicity following continuous etomidate infusion for the control of refractory cerebral edema. Neurosurgery 1995;37:363\u20139.","journal-title":"Neurosurgery"},{"key":"9065_CR26","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/S0272-6386(97)90577-1","volume":"30","author":"PD Yorgin","year":"1997","unstructured":"Yorgin PD, Theodorou AA, Al-Uzri A, Davenport K, Boyer-Hassen LV, Johnson MI. Propylene glycol-induced proximal renal tubular cell injury. Am J Kidney Dis 1997;30:134\u20139.","journal-title":"Am J Kidney Dis"},{"key":"9065_CR27","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/0002-8703(67)90011-7","volume":"74","author":"S Louis","year":"1967","unstructured":"Louis S, Kutt H, Macdowell F. The cardiocirculatory changes caused by intravenous dilantin and its solvent. Am Heart J 1967;74:523\u20139.","journal-title":"Am Heart J"},{"key":"9065_CR28","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1592\/phco.23.10.1094.32762","volume":"23","author":"NE Yaucher","year":"2003","unstructured":"Yaucher NE, Fish JT, Smith HW, Wells JA. Propylene glycol associated renal toxicity from lorazepam infusion. Pharmacotherapy 2003;23:1094\u20139.","journal-title":"Pharmacotherapy"},{"key":"9065_CR29","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1097\/00003246-198608000-00021","volume":"14","author":"L Verressen","year":"1986","unstructured":"Verressen L. Nitroglycerin-induced intracranial hypertension. Crit Care Med 1986;14:753.","journal-title":"Crit Care Med"},{"key":"9065_CR30","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/S0022-3476(78)81183-4","volume":"93","author":"K Arulananthum","year":"1978","unstructured":"Arulananthum K, Genel M. Central nervous system toxicity associated with ingestion of propylene glycol. J Pediatr 1978;93:515\u20136.","journal-title":"J Pediatr"}],"container-title":["Neurocritical Care"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12028-008-9065-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12028-008-9065-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12028-008-9065-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T02:06:43Z","timestamp":1559441203000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12028-008-9065-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,2,13]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,8]]}},"alternative-id":["9065"],"URL":"https:\/\/doi.org\/10.1007\/s12028-008-9065-z","relation":{},"ISSN":["1541-6933","1556-0961"],"issn-type":[{"value":"1541-6933","type":"print"},{"value":"1556-0961","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,2,13]]}}}